FDA BSM
Bristol-Myers Squibb liver cancer drug combo gets FDA approval
March 12, 2020Business Services Bristol; Myer Squibb, FDA, FDA BSM, FDA approvals
The FDA announced on Wednesday that it approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy to treat patients with hepatocellular …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
